Literature DB >> 22183508

Genetic determinants of urolithiasis.

Carla G Monico1, Dawn S Milliner.   

Abstract

Urolithiasis affects approximately 10% of individuals in Western societies by the seventh decade of life. The most common form, idiopathic calcium oxalate urolithiasis, results from the interaction of multiple genes and their interplay with dietary and environmental factors. To date, considerable progress has been made in identifying the metabolic risk factors that predispose to this complex trait, among which hypercalciuria predominates. The specific genetic and epigenetic factors involved in urolithiasis have remained less clear, partly owing to the candidate gene and linkage methods that have been available until now, being inherently low in their power of resolution and in assessing modest effects in complex traits. However, together with investigations of rare, Mendelian forms of urolithiasis associated with various metabolic risk factors, these methods have afforded insights into biological pathways that seem to underlie the development of stones in the urinary tract. Monogenic diseases account for a greater proportion of stone formers in children and adolescents than in adults. Early diagnosis of monogenic forms of urolithiasis is of importance owing to associated renal injury and other potentially treatable disease manifestations, but diagnosis is often delayed because of a lack of familiarity with these rare disorders. In this Review, we will discuss advances in the understanding of the genetics underlying polygenic and monogenic forms of urolithiasis.
© 2012 Macmillan Publishers Limited. All rights reserved

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22183508      PMCID: PMC3901084          DOI: 10.1038/nrneph.2011.211

Source DB:  PubMed          Journal:  Nat Rev Nephrol        ISSN: 1759-5061            Impact factor:   28.314


  110 in total

1.  Sequence variants in the CLDN14 gene associate with kidney stones and bone mineral density.

Authors:  Gudmar Thorleifsson; Hilma Holm; Vidar Edvardsson; G Bragi Walters; Unnur Styrkarsdottir; Daniel F Gudbjartsson; Patrick Sulem; Bjarni V Halldorsson; Femmie de Vegt; Frank C H d'Ancona; Martin den Heijer; Leifur Franzson; Claus Christiansen; Peter Alexandersen; Thorunn Rafnar; Kristleifur Kristjansson; Gunnar Sigurdsson; Lambertus A Kiemeney; Magnus Bodvarsson; Olafur S Indridason; Runolfur Palsson; Augustine Kong; Unnur Thorsteinsdottir; Kari Stefansson
Journal:  Nat Genet       Date:  2009-06-28       Impact factor: 38.330

2.  The natural history of renal and ureteric calculi.

Authors:  V Marshall; R H White; M C De Saintonge; G C Tresidder; J P Blandy
Journal:  Br J Urol       Date:  1975-04

3.  Adenine phosphoribosyltransferase: a simple spectrophotometric assay and the incidence of mutation in the normal population.

Authors:  L A Johnson; R B Gordon; B T Emmerson
Journal:  Biochem Genet       Date:  1977-04       Impact factor: 1.890

4.  Novel paracellin-1 mutations in 25 families with familial hypomagnesemia with hypercalciuria and nephrocalcinosis.

Authors:  Stefanie Weber; Linda Schneider; Melanie Peters; Joachim Misselwitz; Gabriele Rönnefarth; Michael Böswald; Klaus E Bonzel; Tomas Seeman; Tereza Suláková; Eberhard Kuwertz-Bröking; Alojz Gregoric; Jean-Bernard Palcoux; Velibor Tasic; Friedrich Manz; Karl Schärer; Hannsjörg W Seyberth; Martin Konrad
Journal:  J Am Soc Nephrol       Date:  2001-09       Impact factor: 10.121

5.  Partial hypoxanthine-guanine phosphoribosyltransferase deficiency due to a newly recognized mutation presenting with renal failure in a one-year-old boy.

Authors:  Yasushi Ishida; Asako Ishimaru; Hisamichi Tauchi; Akiko Yamaguchi; Masayoshi Yokoyama; Kazuhiro Hiroi; Nobuaki Wakamatsu; Yasukazu Yamada
Journal:  Eur J Pediatr       Date:  2007-09-21       Impact factor: 3.183

6.  A novel missense mutation in SLC34A3 that causes hereditary hypophosphatemic rickets with hypercalciuria in humans identifies threonine 137 as an important determinant of sodium-phosphate cotransport in NaPi-IIc.

Authors:  Graciana Jaureguiberry; Thomas O Carpenter; Stuart Forman; Harald Jüppner; Clemens Bergwitz
Journal:  Am J Physiol Renal Physiol       Date:  2008-05-14

7.  TRPV5 gene polymorphisms in renal hypercalciuria.

Authors:  Kirsten Y Renkema; Kyupil Lee; Catalin N Topala; Monique Goossens; Pascal Houillier; René J Bindels; Joost G Hoenderop
Journal:  Nephrol Dial Transplant       Date:  2009-01-08       Impact factor: 5.992

Review 8.  [Inherited monogenic kidney stone diseases: recent diagnostic and therapeutic advances].

Authors:  Paul Jungers; Dominique Joly; Anne Blanchard; Marie Courbebaisse; Bertrand Knebelmann; Michel Daudon
Journal:  Nephrol Ther       Date:  2008-05-22       Impact factor: 0.722

Review 9.  Primary hyperoxaluria type 1: update and additional mutation analysis of the AGXT gene.

Authors:  Emma L Williams; Cecile Acquaviva; Antonio Amoroso; Francoise Chevalier; Marion Coulter-Mackie; Carla G Monico; Daniela Giachino; Tricia Owen; Angela Robbiano; Eduardo Salido; Hans Waterham; Gill Rumsby
Journal:  Hum Mutat       Date:  2009-06       Impact factor: 4.878

Review 10.  Hypoxanthine-guanine phosophoribosyltransferase (HPRT) deficiency: Lesch-Nyhan syndrome.

Authors:  Rosa J Torres; Juan G Puig
Journal:  Orphanet J Rare Dis       Date:  2007-12-08       Impact factor: 4.123

View more
  25 in total

Review 1.  Epidemiology of stone disease across the world.

Authors:  Igor Sorokin; Charalampos Mamoulakis; Katsuhito Miyazawa; Allen Rodgers; Jamsheer Talati; Yair Lotan
Journal:  World J Urol       Date:  2017-02-17       Impact factor: 4.226

Review 2.  Renal phosphate handling and inherited disorders of phosphate reabsorption: an update.

Authors:  Carsten A Wagner; Isabel Rubio-Aliaga; Nati Hernando
Journal:  Pediatr Nephrol       Date:  2017-12-23       Impact factor: 3.714

3.  Chlorthalidone Is Superior to Potassium Citrate in Reducing Calcium Phosphate Stones and Increasing Bone Quality in Hypercalciuric Stone-Forming Rats.

Authors:  Nancy S Krieger; John R Asplin; Ignacio Granja; Felix M Ramos; Courtney Flotteron; Luojing Chen; Tong Tong Wu; Marc D Grynpas; David A Bushinsky
Journal:  J Am Soc Nephrol       Date:  2019-05-17       Impact factor: 10.121

4.  Effect of Potassium Citrate on Calcium Phosphate Stones in a Model of Hypercalciuria.

Authors:  Nancy S Krieger; John R Asplin; Kevin K Frick; Ignacio Granja; Christopher D Culbertson; Adeline Ng; Marc D Grynpas; David A Bushinsky
Journal:  J Am Soc Nephrol       Date:  2015-04-08       Impact factor: 10.121

5.  Geographic location is an important determinant of risk factors for stone disease.

Authors:  Ethan B Fram; Matthew D Sorensen; Vincent G Bird; Joshua M Stern
Journal:  Urolithiasis       Date:  2016-10-24       Impact factor: 3.436

6.  1,25(OH)₂D₃ induces a mineralization defect and loss of bone mineral density in genetic hypercalciuric stone-forming rats.

Authors:  Adeline H Ng; Kevin K Frick; Nancy S Krieger; John R Asplin; Madison Cohen-McFarlane; Christopher D Culbertson; Kelly Kyker-Snowman; Marc D Grynpas; David A Bushinsky
Journal:  Calcif Tissue Int       Date:  2014-01-31       Impact factor: 4.333

7.  Persistence of 1,25D-induced hypercalciuria in alendronate-treated genetic hypercalciuric stone-forming rats fed a low-calcium diet.

Authors:  Kevin K Frick; John R Asplin; Christopher D Culbertson; Ignacio Granja; Nancy S Krieger; David A Bushinsky
Journal:  Am J Physiol Renal Physiol       Date:  2014-02-26

8.  Kidney stones: a fetal origins hypothesis.

Authors:  Sarah A Howles; Mark H Edwards; Cyrus Cooper; Rajesh V Thakker
Journal:  J Bone Miner Res       Date:  2013-12       Impact factor: 6.741

9.  Increased biological response to 1,25(OH)(2)D(3) in genetic hypercalciuric stone-forming rats.

Authors:  Kevin K Frick; John R Asplin; Murray J Favus; Christopher Culbertson; Nancy S Krieger; David A Bushinsky
Journal:  Am J Physiol Renal Physiol       Date:  2013-01-23

10.  Association study of DGKH gene polymorphisms with calcium oxalate stone in Chinese population.

Authors:  Yong Xu; Guohua Zeng; Zanlin Mai; Lili Ou
Journal:  Urolithiasis       Date:  2014-08-01       Impact factor: 3.436

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.